PHOENIX, ARIZONA (April 12, 2022) – Today, Dr. Scott Perkins of Barnet Dulaney Perkins Eye Center, an affiliate of American Vision Partners, became the first surgeon in the Southwest to implant a new solution for the correction of myopia and myopia with astigmatism: EVO Visian ICL.
Myopia, which is also known as nearsightedness or the need for distance vision correction, is the most common vision disorder globally and its prevalence is rapidly growing. (1) An estimated 100 million U.S. adults ages 21 to 45 who have myopia are potential candidates for EVO, a biocompatible implantable lens that corrects distance vision. (2)
“Following FDA approval, prospective patients in the U.S. and their doctors may now consider EVO for achieving Visual Freedom from the limitations, ongoing maintenance and inconvenience associated with glasses and contact lenses,” said Caren Mason, President and CEO of STAAR Surgical. “Over one million EVO lenses have already been implanted by doctors outside the U.S. and 99.4% of EVO patients in a survey have stated they would have the procedure again.” (3)
Dr. Scott Perkins, surgeon and founding partner at Barnet Dulaney Perkins Eye Center in Arizona, took part in the FDA clinical trials for the EVO Visian ICL. He was the first surgeon in the Southwest United States to implant the innovative solution to correct myopia and myopia with astigmatism.
“The new EVO ICL is the newest tool that we have in our tool box to treat nearsightedness and astigmatism. The results have been remarkable. I’m so pleased to be able to now offer this to our patients”, says Dr. Perkins.
To learn more about the EVO Visian ICL and whether you may be a candidate, please go to https://bdplasik.com/evo-visian-icl-lenses/ or https://www.goodeyes.com/evo-visian-icl-lens/ You can also call 602-598-7600 to schedule a free consultation to see if you’re qualified for the new EVO Visian ICL.
(1) Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016.
(2) Market Scope, Refractive Surgery Report, 2019 and Company estimates. Company estimates that more than one in three of the 330 million U.S. population is between 21-45 years old with myopia greater than -3.0 D and has the willingness to undergo an EVO procedure, the financial ability to pay for EVO and is relatively close in terms of distance to a certified surgeon.
(3) Packer, The Implantable Collamer Lens with a central port: review of the literature, Clinical Ophthalmology, 2018.
About Barnet Dulaney Perkins Eye Center
The doctors at Barnet Dulaney Perkins Eye Center are recognized leaders in providing state-of-the-art medical and surgical eye care in Arizona for more than 35 years. Doctors at Barnet Dulaney Perkins Eye Center use the most advanced technologies and techniques to treat patients at all stages of life. Comprehensive eye health services are provided by nationally renowned specialists in multiple fields of ophthalmology, including cataract surgery, vision correction, cornea, retina, glaucoma, and oculoplastics. Patients can expect compassionate and convenient care from the doctors of any of the Barnet Dulaney Perkins Eye Center clinics. For more information, please visit www.GoodEyes.com.